Growth Metrics

AVITA Medical (RCEL) Gross Profit (2018 - 2025)

AVITA Medical filings provide 8 years of Gross Profit readings, the most recent being $14.3 million for Q4 2025.

  • On a quarterly basis, Gross Profit fell 11.26% to $14.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $58.8 million, a 6.63% increase, with the full-year FY2025 number at $58.8 million, up 6.63% from a year prior.
  • Gross Profit hit $14.3 million in Q4 2025 for AVITA Medical, up from $13.9 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $16.4 million in Q3 2024 to a low of $5.8 million in Q1 2022.
  • Median Gross Profit over the past 5 years was $10.6 million (2023), compared with a mean of $11.0 million.
  • Biggest five-year swings in Gross Profit: surged 174.76% in 2021 and later dropped 15.17% in 2025.
  • AVITA Medical's Gross Profit stood at $5.9 million in 2021, then soared by 36.68% to $8.1 million in 2022, then skyrocketed by 52.92% to $12.4 million in 2023, then soared by 30.06% to $16.1 million in 2024, then decreased by 11.26% to $14.3 million in 2025.
  • The last three reported values for Gross Profit were $14.3 million (Q4 2025), $13.9 million (Q3 2025), and $14.9 million (Q2 2025) per Business Quant data.